If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 19 Similar Profiles
Ovarian Neoplasms Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Carcinoma Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Small Interfering RNA Medicine & Life Sciences
Growth Medicine & Life Sciences
MicroRNAs Medicine & Life Sciences
docetaxel Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1994 2018

9 Citations

A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers

The Cancer Genome Atlas Research Network, Apr 9 2018, In : Cancer Cell. 33, 4, p. 690-705.e9

Research output: Contribution to journalArticle

Breast Neoplasms
Atlases
Long Noncoding RNA
Decision Trees
Genome
1 Citations

ADH1B promotes mesothelial clearance and ovarian cancer infiltration

Gharpure, K. M., Lara, O. D., Wen, Y., Pradeep, S., LaFargue, C., Ivan, C., Rupaimoole, R., Hu, W., Mangala, L. S., Wu, S., Nagaraja, A. S., Baggerly, K. A. & Sood, A. K., May 18 2018, In : Oncotarget. 9, 38, p. 25115-25126 12 p.

Research output: Contribution to journalArticle

Ovarian Neoplasms
Neoplasms
Adjuvant Chemotherapy
Cell Adhesion
Extracellular Matrix
14 Citations

An Integrated TCGA Pan-Cancer Clinical Data Resource to Drive High-Quality Survival Outcome Analytics

The Cancer Genome Atlas Research Network, Apr 5 2018, In : Cell. 173, 2, p. 400-416.e11

Research output: Contribution to journalArticle

Atlases
Genes
Genome
Survival
Neoplasms
6 Citations

A Pan-Cancer Analysis of Enhancer Expression in Nearly 9000 Patient Samples

The Cancer Genome Atlas Research Network, Apr 5 2018, In : Cell. 173, 2, p. 386-399.e12

Research output: Contribution to journalArticle

Genes
Tumors
Neoplasms
Computational methods
Chromatin

A practical guide for the safe implementation of early phase drug development and immunotherapy program in gynecologic oncology practice

Jazaeri, A. A., Coleman, R., Sood, A. K., Frumovitz, M., Soliman, P. T., Shafer, A., Cutrera, J. J., Klinger, M., Sharafi, S. E., Johnson, C. A. L., Villanueva, V. F., Hinchcliff, E. M., Dickens, A., Cain, K. E., Anderson, J. E., Lu, K. H. & Westin, S. N., Nov 1 2018, In : Gynecologic oncology. 151, 2, p. 374-380 7 p.

Research output: Contribution to journalReview article

Immunotherapy
Pharmaceutical Preparations
Neoplasms
Therapeutics
Clinical Trials